FDA CDRH Variance Approval Letter for Photon GFX
Summary
The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Photon GFX. This notice indicates a specific approval for a medical device variance, though no further details or documents are available for review.
What changed
The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Photon GFX. This document, identified by FDA-2026-V-1684-0003, signifies a specific regulatory approval for a device variance. However, the content of the approval letter and any associated documents are not available for public viewing or download through the provided link.
Given the limited information, it is unclear what specific actions, if any, are required by other medical device manufacturers. Compliance officers should note this as an informational item regarding FDA's regulatory actions for specific device variances. No immediate compliance actions or deadlines are apparent from this notice.
Source document (simplified)
Content
There are no documents available to view or download
Attachments 1
Variance Approval Letter from FDA CDRH to Photon GFX
More Information
- Author(s) CDRH
Download
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.